You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm is focused on moving more of its business into the molecular diagnostics market, and it believes the recent CLIA waiver for its Alere i platform provides it with a market opportunity not available to competitors.
With overlapping technologies, some firms pursue parallel human and animal health diagnostics development, but cost constraints and regulatory dynamics differ. Part one of a two-part series.
The waiver opens up a significant new opportunity for Alere within the physician office market, according to a company executive.
The Alere i Influenza A&B assay was originally cleared by FDA in June and the CLIA waiver means the test will be available in a wider variety of healthcare settings.
Trends included expanding test menus and a possible tipping point for point-of-care.
Freeze-drying and rehydrating pooled samples may overcome problems casued by dilution of pathogen nucleic acids.
The additional strains cleared for the Simplexa Flu A/B & RSV Direct kit include influenza A strain H7N9 and H3N2v
Researchers have sequenced the ferret genome.
This story has been updated to include comments on the validity of the published research.
The editorial board of the Pittsburgh Post-Gazette says other lawmakers should take Florida's approach and provide additional protections against genetic discrimination.
The Hill reports 17 states and the District of Columbia are suing over a new policy that would strip international students of their visas if they only attend classes online.
Centers for Disease Control and Prevention employees call on the agency to label racism a public health crisis and examine its own policies, NPR reports.
In PNAS this week: genetic evidence for Inca resettlement, analysis of spermatogonial stem cell transcriptomes, and more.